A U.S. judge on Thursday overturned a $140.1 million verdict against AbbVie Inc. in a lawsuit by a man who claimed the company misrepresented the risks of its testosterone replacement drug AndroGel, causing him to suffer a heart attack. U.S. …
from News – Insurance Journal https://ift.tt/2lYG1Dr
via
IFTTT
No comments:
Post a Comment